Bringing the fundamentals into focus…
Back to Capricor Therapeutics, Inc.
How Capricor Therapeutics, Inc. stacks up
CAPR · against 441 other Healthcare companies of similar size
Profitability
17/ 100
Near the bottom of its peers.
Ranked #360 of 442 · scores higher than 17% of peers
Bars: peers in each 10-point band of the profitability score45 peers with a profitability score of 10–19, including CAPR · Click a bar to see the companies
Why profitability scores 17?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 88% of peers. Return on assets: -35.1% vs peer median 1.7%
- a lower return on invested capital: weaker than 87% of peers. Return on invested capital: -47.4% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = CAPR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CAPR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 413 reported | -47.4% | 1.8% | 14% | 33% | |
| Operating marginHigher is better · 414 reported | Not reported | 4.7% | — | — | 33% |
| Return on assetsHigher is better · 439 reported | -35.1% | 0.8% | 13% | 33% | |
| Return on equityHigher is better · 419 reported | -73.7% | 0.8% | 10% | Context only | |
| Gross marginHigher is better · 459 reported | 0.0% | 39.6% | 4% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around CAPR| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 357 | 749M USD | 18 | 39 | |
| 360 | 222M GBP (≈$288M) | 17 | 13 | |
| 360 | 647M USD | 17 | 40 | |
| 360 | 593M USD | 17 | 40 | |
| 360 | 479M USD | 17 | 34 | |
| 360 | 393M USD | 17 | 50 | |
| 360 | 255M USD | 17 | 38 | |
| 360 | 276M USD | 17 | 46 | |
| 360 | 519M USD | 17 | 22 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score